[1] |
Xiya MA,Hu JI,Zehua ZHU,Bo PAN,Qiang XIE,Xiaobo. YAO.
The predictive value of 18F⁃FDG PET/CT metabolic heterogeneity parameters combined with clinical features for the prognosis of esophageal squamous cell carcinoma before definitive radiochemotherapy
[J]. The Journal of Practical Medicine, 2024, 40(7): 966-971.
|
[2] |
Bing′er WU,Qing LI,Kerong YANG,Jian ZHANG,Yi YU,Lei LEI,Bo. HU.
Impact of spermidine on proliferation and apoptosis in diffuse large B⁃cell lymphoma cell lines
[J]. The Journal of Practical Medicine, 2024, 40(22): 3130-3137.
|
[3] |
Yanrui ZHANG,Xinyi HUANG,Jian SHI,Yihui YANG,Limin LIU,Haiyan HU.
A clinicopathological analysis of cervical carcinoma with basaloid features
[J]. The Journal of Practical Medicine, 2024, 40(2): 163-168.
|
[4] |
Sishi XU,Peipei. YE.
Clinical research progress of BTK inhibitors in the treatment of mantle cell lymphoma
[J]. The Journal of Practical Medicine, 2024, 40(17): 2363-2368.
|
[5] |
Hua JIANG,Limin ZHANG,Dan WANG,Ping HAN,Yuehong SUN,Yuwen LI,Chenxi ZHANG,Wencan JIANG,Xiao LI,Hui. ZHAO.
Clinical value of joint detection of cerebrospinal fluid and blood routine indicators in differentiating between multiple gliomas and primary central nervous system lymphoma
[J]. The Journal of Practical Medicine, 2024, 40(13): 1864-1868.
|
[6] |
YANG Yuanyuan, SHI Mingxia..
Advances in the diagnosis and treatment of secondary cardiac lymphoma
[J]. The Journal of Practical Medicine, 2023, 39(9): 1067-1071.
|
[7] |
FAN Dandan, HU Maogui, DING Kaiyang, CAO Linlin, FENG Yuanyuan, WANG Cuicui, MING Jing, SONG Hao, WANG Xinchen..
Comparing the efficacy and safety of rituximab with other biosimilars combined with CHOP regimen in the treatment of patients with newly diagnosed diffuse large B⁃cell lymphoma
[J]. The Journal of Practical Medicine, 2023, 39(8): 1022-1028.
|
[8] |
DING Shu, HAN Zhuoying, ZHANG Bowei, YU Weiyong, LUO Chao..
Clinical significance of SLC5A12 expression in esophageal squamous cell carcinoma and its effect on malig⁃ nant phenotype of esophageal squamous cell carcinoma
[J]. The Journal of Practical Medicine, 2023, 39(6): 730-737.
|
[9] |
WENG Xu, WU Donghui, MA Wentao, PENG He..
lncRNA PCAT19 targeted miR ⁃769⁃5p promotes the proliferation,migration and invasion of oral squa⁃ mous cell carcinoma HSC3 cells
[J]. The Journal of Practical Medicine, 2023, 39(4): 417-422.
|
[10] |
Pingping LIN,Fubo LI,Dongjuan WANG,Yan GUO,Yi. DONG.
Impacts of circLRP6 on cisplatin resistance to esophageal squamous cell carcinoma by regulating miR⁃125a⁃5p/MCL1 axis
[J]. The Journal of Practical Medicine, 2023, 39(17): 2183-2189.
|
[11] |
WANG Ya, ZHANG Linjie, WU Nan, XU Jiang, DAI Haitao. .
Expression and clinical significance of TRPV2 in oral squamous cell carcinoma
[J]. The Journal of Practical Medicine, 2023, 39(15): 1913-1918.
|
[12] |
WANG Jing, YANG Yage, ZHENG Xiaoyong, GUO Changqing. .
Efficacy and safety of anlotinib monotherapy as the further ⁃ line treatment for patients with advanced esophageal squamous cell carcinoma
[J]. The Journal of Practical Medicine, 2022, 38(7): 893-899.
|
[13] |
HE Keyao, LIU Yiwen, ZHANG Zheyuan, ZHANG Jiahao, DAI Ningtao, YANG Haijun, KONG Jinyu, ZHOU Fuyou..
The clinical significance of high expression of autophagy regulatory protein LC3 induced by Fn in ESCC
[J]. The Journal of Practical Medicine, 2022, 38(22): 2787-2794.
|
[14] |
CAI Sina, CHEN Jianguang, GUAN Xiaoqian, LIANG Weijiang. .
The difference in serum protein fingerprint between pre⁃ and post⁃surgical treatment for patients with cer⁃ vical squamous cell carcinoma
[J]. The Journal of Practical Medicine, 2022, 38(15): 1890-1895.
|
[15] |
LI Liheng, WANG Rui, WANG Qin, ZHANG Zhiyi, AN Feng, ZHANG Xuan, WANG Xiaoming, ZHANG Fan..
Effect of miR ⁃ 498 targeting PCK1 on growth of oral squamous cell carcinoma cells
[J]. The Journal of Practical Medicine, 2022, 38(11): 1339-1346.
|